4-((2-phenylquinazolin-4-yl) amino)benzoic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 4-((2-phenylquinazolin-4-yl) amino)benzoic acid
• 英文别名: 4-[(2-phenylquinazolin-4-yl)amino]benzoic acid
• 化学式: C₂₁H₁₅N₃O₂
• 分子量: 341.369
• InChiKey: URQSXBUBPRZCPZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  75.1
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-((2-phenylquinazolin-4-yl) amino)benzoic acid 在 氯化亚砜 、 一水合肼 作用下， 以 苯 为溶剂， 反应 8.0h， 生成 4-[(2-phenylquinazolin-4-yl)amino]benzohydrazide
  参考文献：
  名称：

  Synthesis, characterization, and antimicrobial studies of novel 1,3,4-thiadiazolium-5-thiolates

  摘要：

  Sixteen novel thiadiazolium derivatives 6(a-h) and 12(a-h) were synthesized by conventional route starting from anthranilic acid using different acid chloride derivatives. The structure of all the newly synthesized compounds was established by IR, NMR, mass spectroscopy, and elemental analysis. The compounds were also screened for their antibacterial activity against some important bacterial species. Some of the compounds were found excellent active against these species.

  DOI：

  10.1007/s00044-011-9632-2
• 作为产物：
  描述：

  2-苯基-4-[3H]喹唑啉酮 在 三氯氧磷 作用下， 以 异丙醇 为溶剂， 生成 4-((2-phenylquinazolin-4-yl) amino)benzoic acid
  参考文献：
  名称：

  新型喹唑啉-苯并咪唑杂合体的合成和评价作为有效的抗多药耐药金黄色葡萄球菌和结核分枝杆菌的抗菌剂

  摘要：

  由于抗生素抗性的迅速提高，传染病已成为对公共卫生的严重威胁。迫切需要开发具有多种化学结构和新颖的作用机制以克服耐药性的新型抗菌剂。近年来，喹唑啉-苯并咪唑杂合体已作为对金黄色葡萄球菌和结核分枝杆菌有活性的新型抗菌剂出现。在当前的研究中，我们设计和合成了15种新的喹唑啉-苯并咪唑杂种，并评估了它们对金黄色葡萄球菌ATCC 29213和结核分枝杆菌H37Rv的抗菌活性。这些研究导致鉴定出九种有效的抗菌剂8a，8b，图8c，图8d，8f中，8克，8H，8I和10C与在MIC值4-64的范围内μ克/毫升。此外，发现这些选择的化合物对包括耐甲氧西林和耐万古霉素的金黄色葡萄球菌在内的一组耐药临床分离株具有有效的抗菌潜力。被发现的选择的化合物是有毒的Vero细胞（CC少50 = 40≥200 μg / mL），并显示出良好的选择性指数。基于所获得的令人鼓舞的结果，这些新的苯并咪唑-2-基喹唑啉衍生物已成

  DOI：

  10.1016/j.ejmech.2020.112996

文献信息

• Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)
  作者：Michael K. Krapf、Michael Wiese

  DOI：10.1021/acs.jmedchem.6b00330

  日期：2016.6.9

  of cancer often fails due to overexpression of the ATP-binding cassette (ABC) transport proteins, like ABCG2, triggering active efflux of various structurally unrelated drugs. This so-called multidrug resistance (MDR) may be reversed by selective, potent, and nontoxic inhibitors of ABCG2. As only a few potent inhibitors are known, new compounds based on a 4-substituted-2-phenylquinazoline scaffold

  癌症的化学疗法治疗通常会因ATP结合盒（ABC）转运蛋白（如ABCG2）的过表达而失败，从而触发各种结构上不相关的药物的主动流出。这种所谓的多药耐药性（MDR）可以通过ABCG2的选择性，有效和无毒抑制剂来逆转。因为仅已知几种有效的抑制剂，所以研究了基于4-取代的-2-苯基喹唑啉骨架的新化合物。用羟基，氰基，硝基，乙酰胺基和氟取代可导致对ABCG2的高度抑制活性。在MTT功效测定中证实了逆转最具活性的化合物的MDR的能力。此外，发现可忽略的低固有细胞毒性导致高治疗率。对于喹唑啉化合物，对ABCB1和ABCC1的抑制活性的研究产生了对ABCG2的高选择性。基于喹啉的类似物显示较低的抑制活性和选择性。该研究产生了各种有希望的化合物，其中一些具有比标准抑制剂Ko143更好的性能。
• COMPOSITIONS AND METHODS FOR MODULATING GATED ION CHANNELS
  申请人：VOHRA Rahul

  公开号：US20090023773A1

  公开（公告）日：2009-01-22

  Disclosed are compounds that modulate the activity of the gated ion channels. Compounds that modulate these gated ion channels are useful in the treatment of diseases and disorders related to pain, inflammation, the neurological system, the gastrointestinal system and genitourinary system. Preferred compounds include compounds of the Formulae 1, 2, 3, 4, and 5.

  本文披露了调节门控离子通道活性的化合物。调节这些门控离子通道的化合物在治疗与疼痛、炎症、神经系统、胃肠系统和泌尿系统相关的疾病和障碍方面具有用处。优选化合物包括式1、2、3、4和5的化合物。
• Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives
  作者：Hassan M. Shallal、Wade A. Russu

  DOI：10.1016/j.ejmech.2011.02.057

  日期：2011.6

  Protein kinases play several pertinent roles in cell proliferation, and targeting these proteins has been shown to be a successful strategy toward controlling different malignancies. Despite the great discovery stories during the last two decades, there is still a demand for anticancer small molecules with the potential of being selective on both the protein kinase and/or the cellular level. A series of novel piperazinylpyrimidine compounds were synthesized and tested for their potential to selectively inhibit the growth of certain tumor cell lines included within the NCI-60 cell line panel. MDA-MB-468, a triple-negative/basal-like breast carcinoma, cell line was among the most sensitive cell lines towards compounds 4 and 15. The three most interesting compounds identified in cellular screens (4, 15, and 16) were subjected to kinase profiling and found to have an interesting selective tendency to target certain kinase subfamily members; PDGFR, CK1, RAF and others. Compound 4 showed a selective tendency to bind to and/or inhibit the function of certain KIT and PDGFRA mutants compared to their wild-type isoforms. Piperazinylpyrimidine based derivatives represent a new class of selective kinase inhibitors. Significantly 4 is more potent at inhibiting oncogenic mutant forms of PDGFR family kinases, which is relevant in terms of its potential use in treating tumors that have become resistant to treatment or driven by such mutations. The clinical demand for agents useful in the control of triple-negative/basal-like breast cancer justifies our interest in compound 15 which is a potent growth inhibitor of MDA-MB-468 cell line. (C) 2011 Elsevier Masson SAS. All rights reserved.
• Synthesis and SAR study of acridine, 2-methylquinoline and 2-phenylquinazoline analogues as anti-prion agents
  作者：H. Cope、R. Mutter、W. Heal、C. Pascoe、P. Brown、S. Pratt、B. Chen

  DOI：10.1016/j.ejmech.2006.05.002

  日期：2006.10

  Transmissible spongiform encephalopathies (TSEs) are thought to arise from aggregation of a protease resistant protein denoted PrPSc, which is a misfolded isoform of the normal cellular prion protein PrPC. Using virtual high-throughput screening we have selected structures analogous to acridine, 2-methyquinoline and 2-phenylquinazoline as potential therapeutic candidates for the treatment of TSEs. From the synthesis and screening of constructed libraries we have shown that an electron-rich aromatic ring attached through an amine linker to the position para to the ring nitrogen is beneficial to both binding to PrPC and the suppression of PrPSc accumulation for acridine and 2-methylquinoline analogues. 2-Phenylquinazoline analogues appear to utilise a different mode of action by binding at a different location and/or pose. We report IC(50)s in the nanomolar range. (c) 2006 Elsevier Masson SAS. All rights reserved.
• Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents
  作者：Satyaveni Malasala、Md Naiyaz Ahmad、Jitendra Gour、Manjulika Shukla、Grace Kaul、Abdul Akhir、Srikanth Gatadi、Y.V. Madhavi、Sidharth Chopra、Srinivas Nanduri

  DOI：10.1016/j.molstruc.2020.128493

  日期：2020.10